Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2006 Vol. 1
p
 
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 1
Nanotech 2006 Vol. 1
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 1
 
Chapter 7: Nanoscale Modeling
 

DNA-based Killer Automaton: The Innovative Nanomedicine

Authors:S. Liu and J.-L. Gaudiot
Affilation:University of California Irvine, US
Pages:637 - 640
Keywords:the bystander effect, molecular automaton, DNA computing, homologous GJIC channels
Abstract:Based upon Shapiro’s molecular automaton model, we propose the DNA-based Killer Automaton (DKA), an innovative nanomedicine for cancer treatment. Each DKA is composed of a DNA cancer detector and a cytotoxic chemical. Equipped with an internal DNA Computing algorithm, the DKA cancer detector checks the cell’s mRNA strands to determine whether the cell is cancerous and release the cytotoxic chemical to kill the cell only if the cell is cancerous. In addition, due to the bystander effect, the cytotoxic material carried by DKA will only diffuse to the cells that express cancerous behavior through the homologous GJIC channels, thus completely curing cancer with minimal side effects. In order to predict the efficacy of DKA in cancer treatments, we have constructed a software model to simulate the DKA mechanisms in an artificial multi-cell environment. The results obtained from these simulations show that the efficacy of this nanomedicine is linearly dependent on the dose of injection and the degree of connectivity between cancer cells. Also, the results confirm that due to the bystander effect, as long as DKA can enter five to ten percent of all cancer cells, they are able to propagate to all cancer cells through and thus result in complete tumor regression. In conclusion, it can be inferred from our work that the bystander effect greatly enhances the delivery of nanomedicine in a cancer tumor, thus resulting in a higher killing efficacy.
ISBN:0-9767985-6-5
Pages:871
Hardcopy:$185.00
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact